Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-15

Clinical Trial Update: Insulin Glargine in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting the completion of a study evaluating insulin glargine in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED